CN112481213A - 一种小分子活性肽在诱导hUC-MSCs分化方面的应用 - Google Patents

一种小分子活性肽在诱导hUC-MSCs分化方面的应用 Download PDF

Info

Publication number
CN112481213A
CN112481213A CN202011369787.0A CN202011369787A CN112481213A CN 112481213 A CN112481213 A CN 112481213A CN 202011369787 A CN202011369787 A CN 202011369787A CN 112481213 A CN112481213 A CN 112481213A
Authority
CN
China
Prior art keywords
active peptide
molecule active
small molecule
inducing
differentiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202011369787.0A
Other languages
English (en)
Other versions
CN112481213B (zh
Inventor
张川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dezhou Lanli Biological Technology Co ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202011369787.0A priority Critical patent/CN112481213B/zh
Publication of CN112481213A publication Critical patent/CN112481213A/zh
Application granted granted Critical
Publication of CN112481213B publication Critical patent/CN112481213B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
    • C12N2506/1392—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from mesenchymal stem cells from other natural sources

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

本发明公开了一种小分子活性肽在诱导hUC‑MSCs分化方面的应用，所述小分子活性肽为(D‑ALA2)‑亮氨酸脑啡肽，所述分化指向神经元样细胞分化。本发明发现，小分子活性肽(D‑ALA2)‑亮氨酸脑啡肽具有诱导hUCMSCs向神经元样细胞分化的活性，且具有浓度效应。因此，(D‑ALA2)‑亮氨酸脑啡肽可以用于制备诱导hUCMSCs向神经元样细胞分化的培养基。

Description

一种小分子活性肽在诱导hUC-MSCs分化方面的应用
技术领域
本发明属于干细胞领域，涉及干细胞诱导分化，具体一种小分子活性肽在诱导hUC-MSCs分化方面的应用。
背景技术
间充质干细胞(MSCs)是一类来源于发育早期中胚层、具有多向分化及自我更新潜能的成体干细胞。MSCs的来源主要包括骨髓、脂肪、脐带、胎盘、羊膜等。其中，人脐带间充质干细胞(hUC-MSCs)因取材方便、来源广泛、免疫原性低且不受伦理学争议等众多优势，成为最具潜力的种子细胞。
研究显示，hUC-MSCs具有广阔的临床应用前景，可用于治疗神经系统疾病、肝肾损伤、自身免疫疾病、心脏疾病、骨科疾病、心血管疾病、糖尿病等。
诱导hUC-MSCs向神经元样细胞分化可以用于脊髓损伤等神经损伤相关疾病。
发明内容
本发明是为了提供一种小分子活性肽在诱导hUC-MSCs分化方面的应用。
技术方案：
一种小分子活性肽在体外诱导hUC-MSCs分化方面的应用，其中：所述小分子活性肽为(D-ALA2)-亮氨酸脑啡肽，所述分化指向神经元样细胞分化。
一种小分子活性肽在制备体外诱导hUC-MSCs向神经元样细胞分化的培养基方面方面的应用，所述小分子活性肽为(D-ALA2)-亮氨酸脑啡肽。
技术效果：
本发明发现，小分子活性肽(D-ALA2)-亮氨酸脑啡肽具有诱导hUCMSCs向神经元样细胞分化的活性，且具有浓度效应。因此，(D-ALA2)-亮氨酸脑啡肽可以用于制备诱导hUCMSCs向神经元样细胞分化的培养基。
附图说明
图1为人脐带间充质干细胞倒置显微镜观察结果；可见细胞呈梭形，呈漩涡状生长，符合人脐带间充质干细胞的生长特点。
图2为各组继续培养8d后倒置显微镜下观察结果；可见含有20μM或50μM小分子活性肽的加药诱导组可见明显的神经元样细胞，而正常对照组不明显。
图3为Westernblot检测结果；与正常对照组相比，含有20μM或50μM小分子活性肽的加药诱导组NSE蛋白显著升高，且小分子活性肽的浓度越高NSE蛋白含量越高。
具体实施方式
一、实验材料
人脐带间充质干细胞购自上海传秋生物科技有限公司。
胎牛血清、DMEM/F12(1:1)培养基购自购自美国Gibco公司。
小分子活性肽为(D-ALA2)-亮氨酸脑啡肽，序列为H-Tyr-D-Ala-Gly-Phe-Leu-OH(CAS号：64963-01-5)，购自源叶生物，纯度99％。
二、实验方法
1、人脐带间充质干细胞的培养、传代、形态观察和表型检测
将冻存的人脐带间充质干细胞按常规方法复苏后，用含10％胎牛血清的DMEM/F12培养基培养于T25培养瓶中，培养条件为37℃、5％CO2、饱和湿度。2～3d换一次液，待细胞长满瓶底面积80％～90％时传代。传代比例为1:5，步骤为：将0.25％胰酶-0.53mM EDTA消化液与DPBS置于37℃预热，倒掉培养瓶中的培养基，往培养瓶中加入3-5mLDPBS，轻晃洗涤后弃去。使用DPBS将胰酶稀释4倍，往瓶中加2mL稀释后的胰酶，置于室温孵育消化，消化好后加入2mL含血清的完全培养基终止消化。用移液枪轻轻吹打瓶壁上的细胞，使之完全脱落，然后收集细胞悬液并吹打成单个细胞悬液，1200rpm离心5min，弃上清，加入完全培养基重悬细胞，进行传代。
取传代后生长状态良好的人脐带间充质干细胞用于后续实验。
形态观察：在倒置显微镜下观察人脐带间充质干细胞的形态和生长情况，拍照。
表型检测：将人脐带间充质干细胞用0.25％胰酶消化，PBS重悬，制备1×106/mL的细胞悬液。然后取100μL细胞悬液与20μL标记一抗(CD73-PE、CD90-FITC、CD105-APC、CD34-PE、CD45-APC、HLA-DR-FITC)4℃避光孵育1h，上流式细胞仪检测细胞表型分子阳性率。
2、神经元样细胞分化检测
取生长状态良好的hUCMSCs，用含10％胎牛血清的DMEM/F12培养基制成细胞悬液，按每孔2×105个细胞接种于24孔培养板中，37℃、5％CO2、饱和湿度培养24h后，加药诱导组更换为含10％胎牛血清和20μM或50μM小分子活性肽的DMEM/F12培养基继续培养，正常对照组更换为含10％胎牛血清的DMEM/F12培养基继续培养，每2～3d更换一次对应的培养基。继续培养8d后，倒置显微镜下观察细胞形态。收集正常对照组和加药诱导组继续培养10d的细胞，PBS洗涤，裂解液中裂解，使用BCA法测量总蛋白。将蛋白样本通过SDS-PAGE凝胶电泳分离等量的总蛋白，转移到聚偏二氟乙烯膜上，用含5％脱脂牛奶的封闭溶液封闭，加入抗NSE(神经元特异性烯醇化酶)、β-Actin一抗，4℃摇床过夜，加入HRP标记的二抗室温孵育1h，化学发光法显色，凝胶成像仪采集图像。
3、统计学处理
数据采用GraphPad Prism 5.0软件进行统计处理，以x±s表示，两组间比较采用t检验，P＜0.05表示具有显著性差异。
三、实验结果
1、人脐带间充质干细胞形态观察和表型检测结果
倒置显微镜观察结果如图1所示，细胞呈梭形，呈漩涡状生长，符合人脐带间充质干细胞的生长特点。表型检测结果如表1所示，CD34、CD45、HLA-DR表达水平很低，CD73、CD90、CD105表达水平很高，符合人脐带间充质干细胞的表型特点。
表1细胞表型分子阳性率
细胞表型分子阳性率 阳性率(％)
CD73 98.5
CD90 98.8
CD105 98.2
CD34 2.73
CD45 1.69
HLA-DR 0.87
2、神经元样细胞分化检测
各组继续培养8d后，倒置显微镜下观察结果如图2所示，含有20μM或50μM小分子活性肽的加药诱导组可见明显的神经元样细胞，说明加药诱导组hUCMSCs向神经元样细胞分化，且小分子活性肽的浓度越高分化越明显，而正常对照组不明显。
Western blot检测结果如图3所示，与正常对照组相比，含有20μM或50μM小分子活性肽的加药诱导组NSE蛋白显著升高，且小分子活性肽的浓度越高NSE蛋白含量越高。NSE为神经元标志蛋白，常作为反应神经元样细胞分化水平的标志。
综合细胞形态观察和Western blot检测结果可知，小分子活性肽(D-ALA2)-亮氨酸脑啡肽具有诱导hUCMSCs向神经元样细胞分化的活性，且具有浓度效应。因此，(D-ALA2)-亮氨酸脑啡肽可以用于制备诱导hUCMSCs向神经元样细胞分化的培养基。

Claims (2)

1.一种小分子活性肽在体外诱导hUC-MSCs分化方面的应用，其中：所述小分子活性肽为(D-ALA2)-亮氨酸脑啡肽，所述分化指向神经元样细胞分化。
2.一种小分子活性肽在制备体外诱导hUC-MSCs向神经元样细胞分化的培养基方面方面的应用，所述小分子活性肽为(D-ALA2)-亮氨酸脑啡肽。
CN202011369787.0A 2020-11-30 2020-11-30 一种小分子活性肽在诱导hUC-MSCs分化方面的应用 Active CN112481213B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011369787.0A CN112481213B (zh) 2020-11-30 2020-11-30 一种小分子活性肽在诱导hUC-MSCs分化方面的应用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011369787.0A CN112481213B (zh) 2020-11-30 2020-11-30 一种小分子活性肽在诱导hUC-MSCs分化方面的应用

Publications (2)

Publication Number Publication Date
CN112481213A true CN112481213A (zh) 2021-03-12
CN112481213B CN112481213B (zh) 2022-08-09

Family

ID=74937245

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011369787.0A Active CN112481213B (zh) 2020-11-30 2020-11-30 一种小分子活性肽在诱导hUC-MSCs分化方面的应用

Country Status (1)

Country Link
CN (1) CN112481213B (zh)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1549856A (zh) * 2001-04-19 2004-11-24 金炫寿 使间充质干细胞分化为神经细胞的方法
CN105624115A (zh) * 2015-12-03 2016-06-01 王意忠 一种诱导人脐带间充质干细胞分化为神经样细胞的培养基及其诱导方法
CN107058225A (zh) * 2017-02-10 2017-08-18 郑州大学 一种复合诱导培养基以及采用该培养基诱导脐带间充质干细胞成神经元样细胞的方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1549856A (zh) * 2001-04-19 2004-11-24 金炫寿 使间充质干细胞分化为神经细胞的方法
CN105624115A (zh) * 2015-12-03 2016-06-01 王意忠 一种诱导人脐带间充质干细胞分化为神经样细胞的培养基及其诱导方法
CN107058225A (zh) * 2017-02-10 2017-08-18 郑州大学 一种复合诱导培养基以及采用该培养基诱导脐带间充质干细胞成神经元样细胞的方法

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
MARYAM HAFIZI ET AL.: "Exploring the enkephalinergic differentiation potential in adult stem cells for celltherapy and drug screening implications", 《IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY—ANIMAL》 *
王 武等: "人脐带间充质干细胞向神经元样细胞诱导分化：两种方法的比较", 《中国组织工程研究》 *
赵家慧等: "黄芩苷体外诱导人脐带间充质干细胞分化为神经样细胞", 《河北医科大学学报》 *
陈 镭等: "诱导脐血间充质干细胞向神经元样细胞分化", 《中国组织工程研究》 *
陈晓岚等: "枸杞多糖诱导人脐血间充质干细胞向神经元样细胞分化的实验研究", 《现代生物医学进展》 *

Also Published As

Publication number Publication date
CN112481213B (zh) 2022-08-09

Similar Documents

Publication Publication Date Title
TWI338714B (en) Method of isolation and enrichment of mesenchymal stem cells from amniotic fluid
WO2010107159A1 (ko) Znf281을 발현하는 제대혈 유래 줄기세포의 분리방법 및 대량배양 방법
WO2012008813A2 (ko) 양막유래 중간엽 줄기세포 배양을 위한 배지조성물 및 이를 이용한 양막유래 중간엽 줄기세포의 배양방법
CN111826348B (zh) 一种人诱导性多能干细胞来源的间充质干细胞体外高效制备方法和应用
US20190264179A1 (en) Serum-free medium inducing differentiation of umbilical cord mesenchymal stem cell into insulin-secretion-like cell and preparation method and use thereof
KR100802011B1 (ko) 층분리배양법을 이용한 골수에서의 중간엽 줄기세포분리방법
WO2004111208A1 (es) Celulas madres derivadas de cartilago y sus aplicaciones
Yustianingsih et al. Hypoxia enhances self-renewal properties and markers of mesenchymal stem cells
CN115058391B (zh) 一种低氧型脐带间充质干细胞的培养方法
Kil et al. In vitro differentiation of human Wharton's jelly-derived mesenchymal stem cells into auditory hair cells and neurons
Pilbauerova et al. Enzymatic Isolation, Amplification and Characterization of Dental Pulp Stem Cells.
Hassan et al. Isolation of umbilical cord mesenchymal stem cells using human blood derivatives accompanied with explant method
CN106834223B (zh) 诱导脐带间充质干细胞向软骨细胞分化的方法
Shah et al. Current challenges in dedifferentiated fat cells research
CN111690686B (zh) 一种miRNA高表达在促进脐带间充质干细胞体外增殖和成骨分化方面的应用
CN112481213B (zh) 一种小分子活性肽在诱导hUC-MSCs分化方面的应用
CN100453640C (zh) 一种从脐带血中分离多能成体祖细胞的方法
CN115125192A (zh) 一种骨髓上清液及其在细胞培养中的应用
CN112391341B (zh) 一种sdf-1蛋白激活剂用于促进人脐带间充质干细胞体外增殖和分化的用途
Li et al. Differentiation potential of bone marrow mesenchymal stem cells in duck
CN114540284A (zh) 人脐带间充质干细胞成软骨分化诱导剂及其用途
CN113832108A (zh) 一种脐带间充质干细胞外泌体及其抗皮肤衰老用途
KR101627907B1 (ko) Ｚｎｆ２８１을 발현하는 제대혈 유래 줄기세포의 대량 배양방법
CN112481219B (zh) 一种基因高表达在人脐带间充质干细胞体外培养促进其增殖方面的用途
Cebo Characterization of bovine adipose-derived stem cells

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right

Effective date of registration: 20220616

Address after: 202155 No. 492 qiaosong Road, Chengqiao Town, Chongming District, Shanghai (Shanghai Chengqiao Economic Development Zone)

Applicant after: Suxuan (Shanghai) Biotechnology Co.,Ltd.

Address before: Jiangning campus of Nanjing Medical University, 101 longmian Avenue, Jiangning District, Nanjing City, Jiangsu Province, 211166

Applicant before: Zhang Chuan

TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20220719

Address after: No. 532, middle section of Huaxing Road, Hengyuan street, Linyi County, Dezhou City, Shandong Province, 251500

Applicant after: DEZHOU LANLI BIOLOGICAL TECHNOLOGY Co.,Ltd.

Address before: 202155 No. 492 qiaosong Road, Chengqiao Town, Chongming District, Shanghai (Shanghai Chengqiao Economic Development Zone)

Applicant before: Suxuan (Shanghai) Biotechnology Co.,Ltd.

TA01 Transfer of patent application right
GR01 Patent grant
GR01 Patent grant
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: Application of a small molecular active peptide in inducing differentiation of hUC-MSCs

Effective date of registration: 20230103

Granted publication date: 20220809

Pledgee: Linyi County sub branch of Postal Savings Bank of China Ltd.

Pledgor: DEZHOU LANLI BIOLOGICAL TECHNOLOGY Co.,Ltd.

Registration number: Y2022980030070

PE01 Entry into force of the registration of the contract for pledge of patent right